Do I need an in-person exam for Mounjaro in New York?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these prescribed through telehealth? The short answer is yes—but there are important details to understand about how it works, what your state requires, and how to ensure you’re getting safe, legitimate care.

With telehealth expanding rapidly over the past few years, accessing weight loss treatment from home has become not just possible, but increasingly common. However, the rules vary by state, and not all telehealth providers operate the same way. Let’s break down everything you need to know about getting GLP-1 weight loss medications through telehealth in 2025.

Understanding the Federal Framework: Why Telehealth Works for Weight Loss Meds

One of the most important things to understand is that Wegovy, Ozempic, and Mounjaro are not controlled substances. This matters because federal law—specifically the Ryan Haight Act—requires an in-person visit before prescribing controlled medications like Adderall or opioids via telehealth. But since GLP-1 medications fall outside this category, there’s no federal barrier to prescribing them through a video consultation.

During the COVID-19 pandemic, the Drug Enforcement Administration (DEA) temporarily waived even the controlled substance restrictions to expand telehealth access. While those flexibilities for controlled meds have been extended through December 31, 2025, medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) were never subject to those restrictions in the first place.

What this means for you: From a federal standpoint, a licensed healthcare provider can evaluate you via telehealth and prescribe these medications electronically to your pharmacy—as long as they follow proper medical standards and maintain appropriate documentation.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Differences: What You Need to Know

While federal law allows telehealth prescribing of GLP-1 medications, individual states have their own additional requirements. Some states are very telehealth-friendly, while others require extra steps to ensure patient safety.

States That May Require an Initial In-Person Visit

Several states mandate that patients have an in-person physical examination before or shortly after starting weight loss medication therapy:

• Arkansas: One of the most restrictive states for telemedicine overall, requiring an initial in-person exam to establish the patient-provider relationship
• Delaware: Requires a physical exam in person before telehealth prescribing can begin
• Georgia: State policy expects an initial in-person evaluation prior to prescribing obesity medications
• Mississippi: Requires at least one in-person visit as part of the weight management treatment protocol
• New Jersey: Has particularly strict rules requiring a comprehensive in-person exam including lab work before prescribing any weight-loss medication
• North Dakota: Expects a hands-on initial evaluation for weight-loss treatment
• South Carolina: Mandates an initial in-person examination before telehealth follow-ups
• Texas: Standard of care generally dictates an initial in-person exam, though not explicitly required by statute
• Utah: State guidelines encourage an initial in-person baseline evaluation
• Virginia: Requires a comprehensive physical exam, lab tests, and development of a diet/exercise plan at the start of treatment

Important note: Even in these states, telehealth is still available—you’ll just need to have that first visit in person (or shortly after starting), with follow-ups able to be conducted via video.

States With Full Telehealth Access (No In-Person Requirement)

Many states allow the entire treatment journey—from initial consultation through ongoing monitoring—to happen via telehealth:

• California: Explicitly permits telehealth exams as equivalent to in-person for establishing care
• Connecticut: Has permanent telehealth laws with no in-person mandate (though does require behavioral counseling and lifestyle planning)
• Florida: No in-person requirement, but does mandate BMI ≥30 and follow-up visits at least every 3 months
• Illinois: Fully permits telehealth prescribing with no special barriers
• New York: Telehealth exam is sufficient; no in-person visit needed
• Pennsylvania: No in-person mandate for telehealth prescribing
• Washington: A telehealth pioneer with no restrictions on virtual obesity treatment

Special State Requirements to Be Aware Of

Beyond in-person visit requirements, some states have additional rules:

Connecticut requires that weight loss treatment include behavioral counseling and a documented diet and exercise plan.

Florida mandates that patients have a BMI of 30 or higher (or 27+ with comorbidities) and be seen—whether in person or via telehealth—at least once every three months during active treatment.

New Jersey and Virginia both require comprehensive initial evaluations including lab work, physical examination, psychological screening, and personalized lifestyle modification plans. Virginia specifically requires a follow-up visit within 30 days of starting medication.

Who Can Prescribe These Medications? Understanding Provider Qualifications

All states allow physicians (MDs and DOs) to prescribe GLP-1 weight loss medications via telehealth, assuming they’re licensed in your state. But what about Nurse Practitioners (NPs) and Physician Assistants (PAs)?

States With Independent NP Practice

In these states, Nurse Practitioners can prescribe weight loss medications independently without physician oversight (usually after meeting experience requirements):

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 hours of practice)
• North Dakota
• Utah (as of 2023)
• Virginia (after 2 years)
• Washington

This is significant because it means these states have more telehealth providers available, often with greater appointment availability and competitive pricing.

States Requiring Physician Collaboration

In other states, NPs and PAs can prescribe these medications but must work under a collaborative agreement or supervisory protocol with a physician:

• Arkansas
• Florida (limited independence in some settings)
• Georgia (recent 2024 law now allows Schedule II prescribing with delegation)
• Illinois
• Mississippi (though legislation for full practice authority is pending)
• New Jersey
• Pennsylvania (independence law passed but regulations still pending)
• South Carolina
• Texas (strict requirements including formal delegation agreements)

From a patient perspective, this usually doesn’t matter much in your day-to-day experience. Whether you see an MD or an NP through a telehealth platform like Klarity Health, you’re getting care from a qualified, licensed professional operating within their state’s legal framework.

How Klarity Health Makes Telehealth Weight Loss Treatment Accessible and Compliant

At Klarity Health, we understand that navigating state-by-state regulations can feel overwhelming. That’s why we’ve built our platform to ensure full compliance while maximizing your convenience:

Provider Availability: We work with licensed physicians and nurse practitioners across multiple states, so you can access care when you need it—often with same-day or next-day appointments.

Transparent Pricing: We accept both insurance and offer cash-pay options with upfront, clear pricing. No surprise bills or hidden fees.

Proper Medical Evaluation: Every patient completes a comprehensive medical intake, discusses their health history via live video consultation, and receives personalized treatment planning—meeting or exceeding every state’s standard of care.

Ongoing Monitoring: We don’t just send a prescription and disappear. Our providers schedule regular follow-ups to monitor your progress, adjust dosing, manage side effects, and ensure the medication is working safely for you.

State-Specific Compliance: Our clinical team stays current with each state’s requirements. If you’re in a state requiring an initial in-person visit, we’ll guide you through that process. If your state allows full telehealth treatment, we make it seamless.

What to Expect: The Telehealth Weight Loss Journey

Initial Consultation

Your first appointment typically involves:

1. Medical History Review: You’ll answer detailed questions about your weight history, previous diet attempts, current medications, medical conditions, and family health history
2. BMI Calculation: You’ll provide your current height and weight (some providers may ask for verification photos)
3. Eligibility Discussion: Your provider will confirm you meet clinical criteria—generally BMI ≥30, or BMI ≥27 with weight-related conditions like high blood pressure or prediabetes
4. Risk Assessment: Screening for contraindications like personal/family history of thyroid cancer, pregnancy plans, history of pancreatitis, or severe GI conditions
5. Treatment Planning: Discussion of medication options (Wegovy vs. Ozempic vs. Mounjaro), expected results, lifestyle modifications, and potential side effects
6. Informed Consent: Clear explanation of risks, benefits, and alternatives to medication therapy

Prescription and Dispensing

Once approved, your provider will electronically send your prescription to a licensed pharmacy. Important: Legitimate telehealth providers only work with FDA-approved, pharmacy-dispensed medications—not compounded versions.

The FDA effectively banned routine compounding of semaglutide in May 2025 due to safety concerns. Any telehealth service offering ‘compounded Wegovy’ or similar should be approached with extreme caution.

Your medication typically arrives as:

• Pre-filled injection pens (most common)
• Titration packs with increasing doses
• 30-day supply initially, with potential for 90-day prescriptions once stable

Ongoing Care and Monitoring

This is where telehealth truly shines—and where responsible providers distinguish themselves:

• Regular Check-ins: Most programs schedule video follow-ups every 4-12 weeks, depending on your state’s requirements and your individual response
• Dose Adjustments: GLP-1 medications typically start at low doses and gradually increase to minimize side effects
• Side Effect Management: Your provider should proactively ask about nausea, constipation, or other GI symptoms and provide strategies to manage them
• Lab Monitoring: Periodic bloodwork (metabolic panel, A1C if diabetic) to ensure metabolic safety
• Weight Tracking: Documentation of your progress and adjustment of treatment if you plateau or experience inadequate response
• Lifestyle Support: Guidance on nutrition, physical activity, and behavioral strategies to maximize results

Red Flags: How to Spot Unsafe or Illegitimate Telehealth Providers

Unfortunately, the popularity of medications like Wegovy has attracted some questionable operators. Watch out for these warning signs:

🚩 Guaranteed prescriptions without a thorough medical evaluation🚩 No video consultation required—just an online questionnaire🚩 Compounded or international versions of semaglutide being offered🚩 No mention of follow-up appointments or ongoing monitoring🚩 Unclear provider credentials or state licensure information🚩 Pressure tactics or ‘limited time offers’ to get you to commit🚩 Skipping informed consent about risks, side effects, and contraindications🚩 No clear business address or clinical affiliation

What to look for instead:✅ Live video consultations with licensed providers✅ Clear documentation of provider credentials and state licenses✅ Transparent pricing for both consultations and medications✅ FDA-approved medications dispensed through licensed pharmacies✅ Comprehensive medical history review✅ Scheduled follow-up appointments✅ Clear policies on medical record access and privacy (HIPAA compliance)✅ Responsive customer support and clinical team

Patient Eligibility: Who Actually Qualifies for These Medications?

One common misconception is that anyone wanting to lose a few pounds can get these medications online. In reality, GLP-1 medications are FDA-approved for specific medical indications:

Clinical Criteria for Weight Loss GLP-1s

Primary indication:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, etc.)

Additional expectations:

• Previous attempts at lifestyle modification (diet and exercise)
• Commitment to ongoing lifestyle changes alongside medication
• No contraindications (see below)
• Realistic expectations about gradual weight loss (typically 1-2 pounds per week)

Who Should NOT Take These Medications

Absolute contraindications include:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy or planning pregnancy within 2 months
• Breastfeeding
• Previous severe allergic reaction to semaglutide or tirzepatide

Relative contraindications (requiring careful consideration):

• History of pancreatitis
• Severe gastroparesis or GI motility disorders
• Diabetic retinopathy (may worsen with rapid glucose changes)
• Active gallbladder disease
• History of eating disorders
• Depression or suicidal ideation (requires close monitoring)

Responsible telehealth providers will screen thoroughly for these conditions and may decline to prescribe if you’re not an appropriate candidate.

The Cost Factor: Insurance vs. Cash Pay

Insurance Coverage

Many insurance plans now cover GLP-1 medications for weight loss, though coverage varies widely:

• Medicare: Does not currently cover weight loss medications (though this may change with pending legislation)
• Medicaid: Coverage varies by state—some states cover Wegovy, others don’t
• Private Insurance: Increasing coverage, but often with prior authorization requirements, step therapy (trying other treatments first), or high copays

When insurance does cover these medications, copays can range from $25-$200 per month depending on your plan.

Cash Pay Options

For those without coverage or who prefer not to use insurance, cash pay pricing varies:

• Brand-name Wegovy: $1,000-$1,500/month without insurance
• Ozempic (off-label): $900-$1,200/month
• Mounjaro/Zepbound: $1,000-$1,400/month

Some telehealth platforms, including Klarity Health, offer competitive cash-pay pricing and can help you explore manufacturer savings programs or pharmacy discount cards that may reduce costs.

Savings Programs:

• Novo Nordisk Savings Card (for Wegovy/Ozempic)
• Eli Lilly Savings Card (for Mounjaro/Zepbound)
• GoodRx or similar discount programs

Comparing Your Options: Wegovy, Ozempic, and Mounjaro

The bottom line: All three medications can be safely prescribed via telehealth. Your provider will recommend which is best based on your medical history, insurance coverage, and treatment goals.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded telehealth access:

What’s Changing in 2026 and Beyond

Federal Level:

• The TREATS Act, reintroduced in October 2025, could make permanent some telehealth prescribing flexibilities currently set to expire
• DEA is expected to issue new rules for telemedicine prescribing of controlled substances (though this won’t affect GLP-1s)
• Continued expansion of Medicare coverage for obesity treatment services

State Level:

• More states considering full practice authority for Nurse Practitioners (pending bills in Mississippi, Pennsylvania, and others)
• Streamlined interstate licensure through compacts, making it easier for providers to offer telehealth across state lines
• Potential standardization of obesity treatment protocols to reduce state-by-state variation

Clinical Advances:

• New GLP-1 medications in development with improved side effect profiles
• Oral GLP-1 options (already available in Rybelsus for diabetes) may expand to obesity treatment
• Combination therapies targeting multiple metabolic pathways

Privacy and Security:States like Washington have enacted strict health data privacy laws (the My Health My Data Act), requiring telehealth platforms to implement additional safeguards for sensitive weight-loss treatment information. Patients can expect enhanced privacy protections as these laws become more common.

Frequently Asked Questions

Do I need to have my camera on during the telehealth visit?

Yes. Federal and state regulations require a live, two-way audio-visual consultation to establish the patient-provider relationship and conduct an appropriate medical evaluation. Phone-only consultations don’t meet the standard of care for prescribing weight loss medications.

Can my provider prescribe across state lines?

No. Your provider must be licensed in the state where you’re physically located at the time of the consultation. If you move or travel to another state, you’ll need to work with a provider licensed in your new location.

How quickly can I get started?

With platforms like Klarity Health, you can often schedule an appointment within 24-48 hours. If approved, your prescription is typically sent to the pharmacy the same day. The main variable is medication availability—GLP-1 medications can sometimes have supply constraints at pharmacies.

What if I experience side effects?

Responsible telehealth providers offer ongoing clinical support. You should be able to message your provider between appointments for side effect management, and schedule urgent video consultations if needed. Nausea, the most common side effect, often improves with dose adjustments and dietary modifications.

Will I have to stay on these medications forever?

Not necessarily. While GLP-1 medications are FDA-approved for chronic weight management, treatment duration is individualized. Some patients achieve their goals and successfully transition to maintenance with lifestyle alone, while others benefit from long-term medication use to prevent weight regain. Your provider will work with you to determine the right approach.

What happens if I miss a dose?

If you miss your weekly injection and it’s been less than 5 days since your scheduled dose, take it as soon as you remember. If more than 5 days have passed, skip that dose and resume your normal schedule. Never double up doses. Your telehealth provider can give you specific guidance for your situation.

Are these medications safe for people with diabetes?

Yes—in fact, Ozempic and Mounjaro were originally developed for type 2 diabetes. If you have diabetes, these medications may offer the dual benefit of improving blood sugar control while supporting weight loss. Your provider will monitor your blood glucose levels and may need to adjust your other diabetes medications to prevent low blood sugar.

Take the Next Step: Getting Started With Telehealth Weight Loss Treatment

If you’re struggling with obesity and previous weight loss attempts haven’t worked, GLP-1 medications prescribed through telehealth could be a safe, effective, and convenient option.

Here’s how to get started:

1. Verify your state’s requirements using the information in this guide to understand what to expect
2. Choose a reputable telehealth provider like Klarity Health that prioritizes compliance, safety, and personalized care
3. Schedule your consultation and gather relevant medical information (current medications, recent lab work if available, weight history)
4. Be honest and thorough in your medical history—withholding information could lead to unsafe prescribing
5. Commit to the full treatment plan, including lifestyle modifications and regular follow-ups

Klarity Health makes the process simple:

• Same or next-day appointments with licensed providers in your state
• Both insurance and cash-pay options with transparent pricing
• Comprehensive care from initial evaluation through ongoing support
• Full compliance with federal and state telehealth regulations

Remember, sustainable weight loss is a journey, not a quick fix. These medications are powerful tools, but they work best when combined with healthy eating, regular physical activity, and behavioral changes. A quality telehealth provider will support you through every step of that journey.

Ready to explore whether telehealth weight loss treatment is right for you? Visit Klarity Health to schedule a consultation with a licensed provider who can evaluate your individual situation and create a personalized treatment plan that fits your life.

Citations and Sources

1. Drug Enforcement Administration. (November 15, 2024). DEA and HHS Extend Telemedicine Flexibilities through 2025. Retrieved from https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. Goldman, T. (November 18, 2024). COVID-era telehealth prescribing extended for Adderall and other drugs. Axios. Retrieved from https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. McDermott Will & Emery. (November 18, 2024). DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025. Retrieved from https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/

4. Goodwin Procter LLP. (March 27, 2024). The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs. Retrieved from https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

5. Nextech. (April 11, 2025). Know Your State’s Laws Around Semaglutide Before You Prescribe. Retrieved from https://www.nextech.com/blog/semaglutide-laws-by-state

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a licensed healthcare provider to determine if weight loss medications are appropriate for your individual situation. Individual results may vary.

Research Currency Statement: Verified as of December 17, 2025. Federal telehealth flexibilities for controlled substances remain in effect through December 31, 2025. State regulations are subject to change; readers should verify current requirements with their state medical board or a licensed healthcare provider.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid